subject area of
- 1,25-Dihydroxyvitamin D3Primes Acute Promyelocytic Cells for TPA-Induced Monocytic Differentiation through Both PKC and Tyrosine Phosphorylation Cascades Academic Article
- A Role for the Cleaved Cytoplasmic Domain of E-cadherin in the Nucleus Academic Article
- Abrogation of G2 checkpoint specifically sensitize p53 defective cells to cancer chemotherapeutic agents. Academic Article
- Akt Is Activated in Response to an Apoptotic Signal Academic Article
- Apoptotic Release of Histones from Nucleosomes Academic Article
- Caspase-8 Activation and Bid Cleavage Contribute to MCF7 Cellular Execution in a Caspase-3-dependent Manner during Staurosporine-mediated Apoptosis Academic Article
- Cleavage of DFF-45/ICAD by Multiple Caspases Is Essential for Its Function during Apoptosis Academic Article
- Differences in Functional Consequences and Signal Transduction Induced by IL-3, IL-5, and Nerve Growth Factor in Human Basophils Academic Article
- Differential effects of putative protein kinase C inhibitors on contraction of rat aortic smooth muscle Academic Article
- Endoplasmic reticulum localized Bcl-2 prevents apoptosis when redistribution of cytochrome c is a late event Academic Article
- Entrapment of Src Protein Tyrosine Kinase in Sugar-Modified Silica Academic Article
- Identification of Small Molecules that Sensitize Resistant Tumor Cells to Tumor Necrosis Factor-Family Death Receptors Academic Article
- Mitochondrio‐nuclear translocation of AIF in apoptosis and necrosis Academic Article
- Oncostatin M Induces Bone Loss and Sensitizes Rat Osteosarcoma to the Antitumor Effect of Midostaurin In vivo Academic Article
- Phase I trial of UCN-01 in combination with topotecan in patients with advanced solid cancers: a Princess Margaret Hospital Phase II Consortium study Academic Article
- Retinoic acid- and staurosporine-induced bidirectional differentiation of human neuroblastoma cell lines Academic Article
- Role for IL-4 in macromolecular transport across human intestinal epithelium Academic Article
- UCN-01 in combination with topotecan in patients with advanced recurrent ovarian cancer: A study of the Princess Margaret Hospital Phase II consortium Academic Article